ACA reports Q2 results after the close on August 7, arriving at a 52-week high and carrying the most defensive options positioning in over a year.
The options market is flashing an unusually loud warning. The put/call ratio jumped to 3.04 on August 5 — its highest reading of the past 52 weeks and more than four standard deviations above its 20-day average of 0.79. That level of hedging demand is extreme by any measure, and it stands in stark contrast to a stock that has climbed 31% in the past week alone, trading at $145.32. Peers TPC and VMI both gained roughly 9–10% on the week, while EME surged 22%, suggesting the construction and engineering group broadly caught a bid — but ACA's options market responded with far more caution than the price action implies.
Short interest tells a much calmer story. Bears hold just 2.3% of the free float short, and while that figure has risen 11% over the past week, the absolute level remains low. Borrow costs are negligible at 0.32%, and availability is vast — roughly 2,825% of current short interest — meaning the lending market imposes no friction on new short positions. There is no squeeze pressure here. The short score is a modest 30.5, barely changed over the past two weeks. Shorts are edging in, but not with conviction.
The analyst community, though thin in coverage, leans constructive. Oppenheimer and Barclays both carry positive ratings, with Barclays raising its target to $140 in May. ACA now trades above that target at $145.32, so the stock has outrun the most recent Street estimate. The bull case centres on the Construction Products segment — projected to generate around 65% of EBITDA — and the barge backlog of $252 million offering a visible recovery path. Bears focus on infrastructure funding risk and commodity price volatility in steel and diesel, headwinds that could compress margins faster than the current EV/EBITDA of 14.5x allows. One factor score stands out: ACA ranks in the 93rd percentile for EPS surprise, meaning the company has a strong historical habit of beating estimates. BlackRock added 441,770 shares in Q2 and T. Rowe Price added 525,161, institutional buying that adds a floor beneath the recent rally.
The earnings print will test whether the underlying business can justify a stock that has run 24% in a month — or whether the record put/call ratio reflects something the price has not yet priced in.
See the live data behind this article on ORTEX.
Open ACA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
